An Open-Label Phase 1/2 Study of INCB039110 in Combination With Osimertinib in Subjects With Non-Small Cell Lung Cancer
a study on Lung Cancer Non-Small Cell Lung Cancer
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at UCSF UCSD
- Dates
- study startedestimated completion
- Principal Investigator
- Dr. Lyudmila Bazhenova (ucsd) Dr. Collin Blakely (ucsf)
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientists at UC Health
- Dr. Lyudmila Bazhenova (ucsd)
- Dr. Collin Blakely (ucsf)
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Incyte Corporation
- ID
- NCT02917993
- Phase
- Phase 1/2
- Study Type
- Interventional
- Last Updated